1.16
price up icon4.50%   0.05
after-market Dopo l'orario di chiusura: 1.13 -0.03 -2.59%
loading
Precedente Chiudi:
$1.11
Aprire:
$1.11
Volume 24 ore:
149.96K
Relative Volume:
0.68
Capitalizzazione di mercato:
$18.63M
Reddito:
-
Utile/perdita netta:
$-11.90M
Rapporto P/E:
-0.00563
EPS:
-206.0125
Flusso di cassa netto:
$-12.75M
1 W Prestazione:
+7.41%
1M Prestazione:
+1.75%
6M Prestazione:
+17.97%
1 anno Prestazione:
+14.85%
Intervallo 1D:
Value
$1.10
$1.16
Intervallo di 1 settimana:
Value
$1.07
$1.18
Portata 52W:
Value
$0.6138
$2.35

Allarity Therapeutics Inc Stock (ALLR) Company Profile

Name
Nome
Allarity Therapeutics Inc
Name
Telefono
401-426-4664
Name
Indirizzo
24 SCHOOL ST., 2ND FLOOR, BOSTON
Name
Dipendente
7
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
ALLR's Discussions on Twitter

Confronta ALLR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ALLR
Allarity Therapeutics Inc
1.16 17.82M 0 -11.90M -12.75M -206.01
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.15 118.84B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
812.27 81.61B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
422.50 53.69B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
822.94 49.49B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
176.00 37.34B 447.02M -1.18B -906.14M -6.1812

Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-28 Iniziato Ascendiant Capital Markets Buy

Allarity Therapeutics Inc Borsa (ALLR) Ultime notizie

pulisher
11:39 AM

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on B - GuruFocus

11:39 AM
pulisher
Jan 01, 2026

Allarity CEO says 2026 represents an ‘inflection point’ - Yahoo Finance

Jan 01, 2026
pulisher
Dec 31, 2025

Cancer drug progress, cash runway updates in Allarity's year-end CEO letter - Stock Titan

Dec 31, 2025
pulisher
Dec 31, 2025

Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders - Sahm

Dec 31, 2025
pulisher
Dec 30, 2025

Allarity Therapeutics, Inc. (NASDAQ:ALLR) Short Interest Down 21.9% in December - Defense World

Dec 30, 2025
pulisher
Dec 23, 2025

Allarity Therapeutics Completes Additional Private Equity Financing - TipRanks

Dec 23, 2025
pulisher
Dec 20, 2025

Is Allarity Therapeutics Inc. stock a buy before product launchesQuarterly Profit Summary & Reliable Breakout Forecasts - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

How strong is Allarity Therapeutics Inc. stock balance sheet2025 Short Interest & Consistent Profit Trading Strategies - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

How Allarity Therapeutics Inc. stock reacts to Fed rate cutsEarnings Overview Summary & Smart Investment Allocation Tips - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Is Allarity Therapeutics Inc. stock oversold or undervalued2025 Stock Rankings & Smart Allocation Stock Tips - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Hedge Fund Bets: How Allarity Therapeutics Inc. stock reacts to Fed rate cuts2025 Major Catalysts & AI Optimized Trading Strategy Guides - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Will Allarity Therapeutics Inc. stock maintain dividend yieldJuly 2025 Final Week & High Conviction Investment Ideas - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Is Allarity Therapeutics Inc. stock a bargain at current levels2025 Sector Review & Verified Stock Trade Ideas - Улправда

Dec 19, 2025
pulisher
Dec 18, 2025

Published on: 2025-12-19 05:31:28 - Улправда

Dec 18, 2025
pulisher
Dec 17, 2025

Allarity Therapeutics Earnings Notes - Trefis

Dec 17, 2025
pulisher
Dec 14, 2025

Allarity Therapeutics Secures $2.5M Through Private Placement - MSN

Dec 14, 2025
pulisher
Dec 09, 2025

Ascendiant Capital Maintains Allarity Therapeutics (ALLR) Buy Recommendation - Nasdaq

Dec 09, 2025
pulisher
Dec 09, 2025

ALLR: Ascendiant Capital Raises Price Target, Maintains Buy Rati - GuruFocus

Dec 09, 2025
pulisher
Dec 08, 2025

Allarity Therapeutics updates CFO employment agreement with full-time terms By Investing.com - Investing.com Australia

Dec 08, 2025
pulisher
Dec 08, 2025

Allarity Therapeutics Appoints Jeffrey Ervin as Full-Time CFO - TipRanks

Dec 08, 2025
pulisher
Dec 08, 2025

Allarity Therapeutics updates CFO employment agreement with full-time terms - Investing.com

Dec 08, 2025
pulisher
Dec 04, 2025

Will Allarity Therapeutics Inc. stock benefit from sector rotationTrade Exit Summary & Trade Opportunity Analysis - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Will Allarity Therapeutics Inc. stock return to pre crisis levelsPortfolio Update Report & High Yield Stock Recommendations - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Can Allarity Therapeutics Inc. stock continue upward trendJuly 2025 Rallies & Long Hold Capital Preservation Plans - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Allarity Therapeutics Inc to offer up to $50 million in securities - marketscreener.com

Dec 03, 2025
pulisher
Nov 30, 2025

How Allarity Therapeutics Inc. stock trades before earningsJuly 2025 Final Week & Free Real-Time Market Sentiment Alerts - BỘ NỘI VỤ

Nov 30, 2025
pulisher
Nov 27, 2025

Published on: 2025-11-28 11:27:30 - moha.gov.vn

Nov 27, 2025
pulisher
Nov 27, 2025

A new trading data show Allarity Therapeutics Inc (ALLR) is showing positive returns. - Setenews

Nov 27, 2025
pulisher
Nov 26, 2025

Allarity Therapeutics Inc. (ALLR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 26, 2025
pulisher
Nov 25, 2025

Metastatic Breast Cancer Pipeline Insights Report 2025: Uncovering Breakthrough Drug Candidates Driving Future Market Growth - The Globe and Mail

Nov 25, 2025
pulisher
Nov 22, 2025

Allarity Therapeutics, Inc. (ALLR) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Nov 22, 2025
pulisher
Nov 19, 2025

Is it too late to sell Allarity Therapeutics Inc.July 2025 Movers & High Yield Equity Trading Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Allarity Therapeutics Inc. stock performs in weak economyShare Buyback & Verified Momentum Stock Watchlist - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Allarity Therapeutics Inc. stock continue upward momentumJuly 2025 Decliners & Daily Stock Trend Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Allarity Therapeutics Inc. stock appeals to analystsPortfolio Performance Report & Technical Pattern Based Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why retail investors pile into Allarity Therapeutics Inc. stockWeekly Loss Report & Verified Momentum Stock Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Allarity Therapeutics Inc. stock reacts to oil pricesWeekly Trading Summary & High Accuracy Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Applying big data sentiment scoring on Allarity Therapeutics Inc.July 2025 Summary & Fast Momentum Entry Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Exit strategy if you’re trapped in Allarity Therapeutics Inc.Market Sentiment Summary & Daily Profit Focused Stock Screening - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 00:17:48 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why hedge funds are buying Allarity Therapeutics Inc. stock2025 Big Picture & Safe Capital Growth Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Real time breakdown of Allarity Therapeutics Inc. stock performanceMarket Trend Report & Weekly High Conviction Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Is Allarity Therapeutics Inc. stock affected by interest rate hikesJuly 2025 Recap & Free Fast Gain Swing Trade Alerts - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Allarity Therapeutics Inc Stock Analysis and ForecastTake Profit Strategies & Smart Trading Plans for Every Investor Type - earlytimes.in

Nov 18, 2025

Allarity Therapeutics Inc Azioni (ALLR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$102.71
price up icon 28.63%
$33.90
price up icon 2.42%
$110.57
price up icon 3.67%
$100.08
price up icon 2.03%
biotechnology ONC
$333.87
price up icon 4.22%
$176.00
price up icon 0.53%
Capitalizzazione:     |  Volume (24 ore):